Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,090 DKK | 0.00% | +8.46% | -18.05% |
27/03 | Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
04/03 | FDA Extends Review of Zevra's Arimoclomol by Three Months | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-18.05% | 5.53M | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+1.46% | 22.18B | |
-16.67% | 21.2B | |
-8.58% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- ORPHA Stock
- News Orphazyme A/S
- Orphazyme A/S : Guggenheim Downgrades Orphazyme to Sell From Neutral